TY - JOUR
T1 - Primary Sjögren's syndrome and the risk of acute myocardial infarction
T2 - A nationwide study
AU - Chiang, Chia Hung
AU - Liu, Chia-Jen
AU - Chen, Ping Jen
AU - Leu, Hsin Bang
AU - Hsu, Chien Yi
AU - Huang, Po-Hsun
AU - Chen, Tzeng-Ji
AU - Lin, Shing Jong
AU - Chen, Jaw-Wen
AU - Chan, Wan Leong
PY - 2013/3
Y1 - 2013/3
N2 - Background: Patients with autoimmune diseases have a high cardiovascular risk. However, few data are available on the risk of acute myocardial infarction (AMI) in patients diagnosed with primary Sjögren's syndrome (PSS). We conducted a large nationwide cohort study to investigate the possible association between PSS and the risk of AMI. Methods: Between the years 2000-2006, a total of 5205 patients with newly diagnosed PSS and no history of AMI were identified from the Registry of Catastrophic Illness, a sub-dataset of the National Health Insurance Research Database in Taiwan. The control group, which consisted of subjects without systemic autoimmune disease or previous AMI, was matched by the date of enrollment, age, gender, history of coronary artery disease, diabetes, hypertension, chronic kidney disease, and hyperlipidemia. The study endpoints were the occurrence of AMI. Results: Of the 5205 subjects with PSS and 5205 controls included in the study, 77 (35 PSS patients and 42 controls) developed AMI during the mean 3.7-year (interquartile range, 2.1-5.1 years) follow-up period. The incidence of AMI was similar in PSS patients and controls (1.91/1000 versus 2.25/1000 person-years). Multivariate analysis adjusted for baseline covariates demonstrated an insignificant association between PSS and AMI [adjusted hazard ratio, 0.86; 95% confidence interval (CI), 0.55-1.35; p = 0.506], suggesting that PSS does not increase the risk of AMI. Conclusions: PSS is not associated with a higher risk of subsequent AMI.
AB - Background: Patients with autoimmune diseases have a high cardiovascular risk. However, few data are available on the risk of acute myocardial infarction (AMI) in patients diagnosed with primary Sjögren's syndrome (PSS). We conducted a large nationwide cohort study to investigate the possible association between PSS and the risk of AMI. Methods: Between the years 2000-2006, a total of 5205 patients with newly diagnosed PSS and no history of AMI were identified from the Registry of Catastrophic Illness, a sub-dataset of the National Health Insurance Research Database in Taiwan. The control group, which consisted of subjects without systemic autoimmune disease or previous AMI, was matched by the date of enrollment, age, gender, history of coronary artery disease, diabetes, hypertension, chronic kidney disease, and hyperlipidemia. The study endpoints were the occurrence of AMI. Results: Of the 5205 subjects with PSS and 5205 controls included in the study, 77 (35 PSS patients and 42 controls) developed AMI during the mean 3.7-year (interquartile range, 2.1-5.1 years) follow-up period. The incidence of AMI was similar in PSS patients and controls (1.91/1000 versus 2.25/1000 person-years). Multivariate analysis adjusted for baseline covariates demonstrated an insignificant association between PSS and AMI [adjusted hazard ratio, 0.86; 95% confidence interval (CI), 0.55-1.35; p = 0.506], suggesting that PSS does not increase the risk of AMI. Conclusions: PSS is not associated with a higher risk of subsequent AMI.
KW - Acute myocardial infarction
KW - Atherosclerosis
KW - Primary Sjögren's syndrome
UR - https://www.scopus.com/pages/publications/84878333512
M3 - Article
AN - SCOPUS:84878333512
SN - 1011-6842
VL - 29
SP - 124
EP - 131
JO - Acta Cardiologica Sinica
JF - Acta Cardiologica Sinica
IS - 2
ER -
